Literature DB >> 7950406

Isolation and characterization of group-I isoallergens from Bermuda grass pollen.

P M Smith1, A Avjioglu, L R Ward, R J Simpson, R B Knox, M B Singh.   

Abstract

Two isoallergens of Cyn d I were isolated using preparative isoelectric focussing, and were designated Cyn d Ia and b. These isoallergens differ in their pI, molecular weight (Cyn d Ia, 32 kD and Cyn d Ib, 31 kD) and their NH2-terminal sequence. Four monoclonal antibodies (Mabs) were produced using Cyn d Ia as antigen. These Mabs recognized both Cyn d Ia and b. One of the Mabs recognized four different pI forms of Cyn d I on 2D gels. The Mabs also recognized cross-reactive epitopes on proteins from eight other grasses including rye grass, timothy grass, Kentucky bluegrass and Johnson grass.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7950406     DOI: 10.1159/000236709

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  5 in total

1.  Pollination modulates expression of the PPAL gene, a pistil-specific beta-expansin.

Authors:  Mario Pezzotti; Richard Feron; Celestina Mariani
Journal:  Plant Mol Biol       Date:  2002-05       Impact factor: 4.076

Review 2.  Molecular biomarkers for grass pollen immunotherapy.

Authors:  Florin-Dan Popescu
Journal:  World J Methodol       Date:  2014-03-26

3.  Plant Stress Scenarios Differentially Affect Expression and IgE Reactivity of Grass Group-1 Allergen (β-Expansin) in Maize and Rice Pollen.

Authors:  Yotin Juprasong; Wisuwat Songnuan
Journal:  Front Allergy       Date:  2022-02-10

4.  Dual function of novel pollen coat (surface) proteins: IgE-binding capacity and proteolytic activity disrupting the airway epithelial barrier.

Authors:  Mohamed Elfatih H Bashir; Jason M Ward; Matthew Cummings; Eltayeb E Karrar; Michael Root; Abu Bekr A Mohamed; Robert M Naclerio; Daphne Preuss
Journal:  PLoS One       Date:  2013-01-07       Impact factor: 3.240

5.  A proteomic style approach to characterize a grass mix product reveals potential immunotherapeutic benefit.

Authors:  Alan Bullimore; Nicola Swan; Wemimo Alawode; Murray Skinner
Journal:  World Allergy Organ J       Date:  2011-09-03       Impact factor: 4.084

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.